Screening for chronic Q-fever is only cost-effective for specific groups RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.
Pneumococcal disease in the elderly The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.
Statement on health care spending Down syndrome Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.
Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.
Promising biobased alternatives to controversial polar aprotic solvents There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .
Number of STIs continues to rise at Dutch STI clinics In the first half of this year more STIs were found in people who have been tested at Dutch STI clinics. The increase pertains to all STIs, with the exception of HIV.
European Antibiotic Awareness Day 2016 Friday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe attention focuses on the threat of antibiotic resistance to people and animals.
EU legislation genetically modified microbial biocontrol agents is fit for purpose EU legislative instruments are sufficient to ensure the safety of such products.
Surveillance and developments National Immunisation Programme 2015-2016 The report provides an overview of effectiveness and safety of vaccines and vaccine research.